Key Insights

Highlights

Treatment Research

2 treatments under study, led by Methylprednisolone

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06266221Phase 3Not Yet Recruiting

Severe Erythema Multiforme - CORTICO

Showing all 1 trials

Research Network

Common Treatments

  • Methylprednisolone1
  • Prednisone1

Active Sponsors

  • Assistance Publique - Hôpitaux de Paris1
  • Assistance Publique Hopitaux De Paris1

Top Investigators

Related Conditions

  • Erythema Multiforme1

Activity Timeline